<p> Retatrutide is a next-generation peptide engineered to target three major metabolic receptors — GIP, GLP-1, and glucagon — supporting advanced metabolic and body composition research. </p> <p> Public clinical investigations have demonstrated significant weight reduction potential, with trial participants reaching up to 17.5% body weight reduction within 24 weeks under controlled study conditions. </p> <p> Retatrutide research is commonly associated with appetite regulation, metabolic optimisation, insulin sensitivity pathways, and sustained fat metabolism analysis. </p> <p> This Vital Edge Science research batch features ultra-pure Retatrutide with 99.3%+ Janoshik-verified purity, supported by public batch verification and Australia/New Zealand fulfilment. </p> <p> Recommended for reconstitution using bacteriostatic water within a pH range of 5.7 to 7.0. </p> <p> Each vial contains 10mg~30mg of research-grade Retatrutide depending on selected variant. </p> <p> <strong>For research use only.</strong> </p>